LAPSE:2023.5467
Published Article
LAPSE:2023.5467
Efficacy and Safety of Modified Huang-Lian-Jie-Du Decoction Cream on Cancer Patients with Skin Side Effects Caused by EGFR Inhibition
Ming-Yang Lee, Mei-Yi Lin, Yu-Ju Chang, Yu-Ting Tseng, I-An Huang, Wan-Ting Huang, Yi-Wen Liu
February 23, 2023
(1) Background: The epidermal growth factor inhibitors (EGFRIs)/tyrosine kinase inhibitors (TKIs) are effective for cancer target therapy, but acneiform rashes or so-called inflammatory papulopustular exanthemas are common (50% to 90%). The conventional therapy for EGFRIs/TKIs-induced skin toxicity is steroids and antibacterial drugs, but it is still ineffective for some patients, and EGFRIs/TKIs dose reduction/interruption may be needed. In this study, a modified Chinese herbal medicine, Huang-Lian-Jie-Du decoction cream with Yin-Cold (YC) medicine characteristic, was investigated for the effect on patients suffering EGFRIs/TKIs-induced skin toxicity. (2) Methods: The modified Huang-Lian-Jie-Du (mHLJD) decoction cream was made from 10 herbal medicines, including 4 major medicines (Huanglian, Huangqin, Huangbo, and Zhizi) in traditional HLJD decoction. Patients with EGFRIs/TKIs-induced skin toxicity were enrolled. Patients were excluded if they also used other cream for skin toxicity. Skin conditions were monitored by follow up every 2 weeks. The patients’ characteristics, the skin toxicities, treatment response, and adverse events were recorded and analyzed until skin problems resolved or the study ended. (3) Results: The mHLJD decoction cream and its sub-packages were stored at 4 °C before use. Thirty-four patients who had grade 1−3 skin toxicities after receiving EGFRIs/TKIs were enrolled. Seven patients withdrew or were excluded. Finally, data from 27 patients were analyzed. The mean grade of rash acneiform was significantly decreased from 2.19 (ranged 1 to 3) to 0.88 (ranged 0 to 2) after mHLJD decoction cream treatment for 4 weeks and to 0.55 (ranged 0 to 2) after mHLJD decoction cream treatment for 8 weeks. Additionally, the mean grade of dry skin was also significantly decreased from 1.57 (ranged 1 to 2) to 0.71 (ranged 0 to 1) after mHLJD decoction cream treatment for 4 weeks. The changes of skin toxicity were significant, with no obvious adverse events. (4) Conclusions: In summary, the mHLJD decoction cream provides benefits for alleviation of EGFRIs/TKIs-induced skin rash acneiform and dry skin. Additionally, no obvious side effects were found in patients using mHLJD decoction cream.
Keywords
Chinese herbal medicine, dry skin, EGFRIs/TKIs, skin rash
Subject
Suggested Citation
Lee MY, Lin MY, Chang YJ, Tseng YT, Huang IA, Huang WT, Liu YW. Efficacy and Safety of Modified Huang-Lian-Jie-Du Decoction Cream on Cancer Patients with Skin Side Effects Caused by EGFR Inhibition. (2023). LAPSE:2023.5467
Author Affiliations
Lee MY: Department of Hematology and Oncology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan; Department of Nursing, Min-Hwei College of Health Care Management, Tainan 73658, Taiwan
Lin MY: Department of Chinese Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan; Department of Food Nutrition and Health Biotechnology, Asian University, Taichung 41354, Taiwan
Chang YJ: Department of Hematology and Oncology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan
Tseng YT: Department of Chinese Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan
Huang IA: Department of Chinese Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan
Huang WT: Clinical Medicine Research Center, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan
Liu YW: Department of Microbiology, Immunology and Biopharmaceuticals, College of Life Sciences, National Chiayi University, Chiayi 60004, Taiwan [ORCID]
Journal Name
Processes
Volume
9
Issue
7
First Page
1081
Year
2021
Publication Date
2021-06-22
Published Version
ISSN
2227-9717
Version Comments
Original Submission
Other Meta
PII: pr9071081, Publication Type: Journal Article
Record Map
Published Article

LAPSE:2023.5467
This Record
External Link

doi:10.3390/pr9071081
Publisher Version
Download
Files
[Download 1v1.pdf] (1.8 MB)
Feb 23, 2023
Main Article
License
CC BY 4.0
Meta
Record Statistics
Record Views
64
Version History
[v1] (Original Submission)
Feb 23, 2023
 
Verified by curator on
Feb 23, 2023
This Version Number
v1
Citations
Most Recent
This Version
URL Here
https://psecommunity.org/LAPSE:2023.5467
 
Original Submitter
Auto Uploader for LAPSE
Links to Related Works
Directly Related to This Work
Publisher Version